Key Trends and Insights
By combining Horizon’s capabilities with PerkinElmer’s life science research and applied genomics portfolios, we will be able to deliver complete workflow solutions to our life science customers working on drug discovery and development. Specifically, Horizon’s innovative reagents, which leverage CRISPR technologies, will come together with PerkinElmer’s imaging, detection, automation and LabChip platforms to provide scalable workflows and quality control capabilities when working with engineered cells.
PerkinElmer Has Acquired Horizon Discovery
EUROIMMUN Launches Novel ELISA for Detection of SARS-CoV-2 Antigen in Acutely Infected Patients
3 Steps to Ensure Data Integrity for Drug Development
Fighting COVID-19 with a Force of Four: Detection, Protection, Prevention and Treatment
Return to Work Challenges and Strategies for the GxP Laboratory Environment
LC 300 UHPLC System
NexION 5000 Multi-Quadrupole ICP Mass Spectrometer
Opera Phenix Plus High-Content Screening System
See all products available for online ordering, view your pricing, check availability, place online orders and check order status.
You successfully added item(s) to your cart